Potential COVID-19 antibody drug made by Singapore firm to be tested on 1,305 local, overseas patients Toggle share menu
Advertisement
Potential COVID-19 antibody drug made by Singapore firm to be tested on 1,305 local, overseas patients
Advertisement Singapore
Potential COVID-19 antibody drug made by Singapore firm to be tested on 1,305 local, overseas patients
Prof Ooi Eng Eong is also a co-founder of biotechnology company Tychan, which developed the world’s first Zika antibody in nine months. (Photo: Tychan)
11 Dec 2020 12:10PM) Share this content
Bookmark
SINGAPORE: A potential COVID-19 antibody drug developed by a Singapore-based company will be tested on 1,305 infected patients locally and abroad, in what would be its final trial before it can be approved for treatment in Singapore.